"At its October meeting, the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) recommended the granting of a marketing authorisation in the European Union (EU) for VarroMed (oxalic acid dihydrate / formic acid). This antiparasitic medicine treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic health concern affecting honey bees worldwide. ...."
Read more here: WiredGOV